Physicians Liaison at Southeast Texas Cardiology Associates, Vascular Center & Vein Clinic
Knowledge is power… Peripheral Artery Disease (PAD) is not only often under diagnosed but also mistreated! Learn the facts #pad #limbsalvage #amputation
PAD is more deadly than most forms of cancer, yet most people do not even know about it. Public awareness, early diagnosis and treatment are very important!! #PAD, #PeripheralArteryDisease, #CLI, #CLTI
For surgical oncologist Dr. Evan Glazer, “Specializing in Tomorrows” means offering the treatments of the future so patients can have a chance at a longer, healthier life. Dr. Glazer works with a multidisciplinary team to find the right treatment for the right patient at the right time – a complex process that involves understanding not only a patient’s diagnosis, but their priorities. Learn how Dr. Glazer uses advanced expertise and state-of-the-art surgical approaches to help patients have better outcomes and get back to life more quickly: https://lnkd.in/emP559Ni
In just 120 minutes, our eagerly awaited online lecture series on brain tumors begins. Take a moment to wrap up what you're doing, and then come join us! Register at shorturl.at/fyQ27 Let's unite to advance knowledge and awareness! #BrainTumorAwareness #MedicalEducation #OnlineLearning #Braintumors
Exciting Announcement: Join us for the 8th COSECSA - CEGS Lecture Series! We are delighted to invite medical professionals to the upcoming lecture featuring Dr. Yesehak Bethlehem, who will be presenting on the intricacies of Brain Tumors. 🗓️ Date: Wednesday, 29th May 2024 🕝 Time: 2:30 PM East African Time Whether you're a seasoned practitioner or a medical student eager to learn, this lecture offers invaluable insights into the diagnosis and management of Brain Tumors. Register now to reserve your spot and join us for this enriching discussion: shorturl.at/fyQ27 Let's come together to advance medical education and enhance patient care! #COSECSA #CEGS #BrainTumors #MedicalEducation
Identifying Castleman disease can be challenging, and diagnosis is a multistep process. This series covers common difficulties in detecting and screening for Castleman. Start learning: https://ow.ly/qs6150QJoLe #RareDiseaseDay #CastlemanDisease #Hematology #Oncology #MedEd
Several tips for young pediatric oncologists - Shushan Hovsepyan International Society of Paediatric Oncology - SIOP American Society of Clinical Oncology (ASCO) SIOP Europe, the European Society for Paediatric Oncology (SIOPE) SIOP Asia 2023 European School of Oncology #Cancer #CancerConferences #PaediatricOncology #SIOP #OncoDaily #Oncology #PediatricOncologists #ASCO
Happy Clinical Trials Day! ⚕️ Today is a global celebration for the role clinical trials play in medical discovery and to honor the many people who work to improve outcomes through clinical trials studies. Clinical trials are research studies that help medical professionals improve the detection and treatment of illnesses. Our clinical trials program enrolls client-owned pets to evaluate the effectiveness of new drugs, find novel uses of old drugs, or investigate new approaches to surgery and/or radiation therapy to treat cancer. Many of the standard treatments used today are the result of clinical trials. We learn valuable information from every patient, and we use this information to improve their care as well as the care of future patients, both pets and people. The FACC Clinical Trials team includes (pictured from left to right): ⚕️ Becca Hill – Trials Coordinator ⚕️ Dr. Megan Gutwillig, Clinical Trials Intern ⚕️ Dr. Kristen Weishaar, Clinical Trials Director ⚕️ Kris Ibis, Clinical Trials RVT Clinical trials are an important way that we learn more about cancer and develop more effective ways to treat it. We might be biased but our Clinical Trials team is the BEST! #ClinicalTrialsDay #NationalCancerResearch Month
On this #PancreaticCancerDay, let's delve into the intricate landscape of pancreatic cancers. While adenocarcinomas claim the majority at 90%, it's equally vital to recognize the significance of pancreatic neuroendocrine tumors (#NETs)💡❗ These less common variants originate from hormone-producing islet cells, presenting unique challenges and considerations in diagnosis and treatment. Understanding the distinctions between these two types is pivotal! As we acknowledge the prevalence of #adenocarcinomas, we must not underestimate the impact of #NETs on patient outcomes. 🌐 Education Empowers: Explore Our Program Dive into the intricacies of pancreatic cancer in our latest micro-learning module! 🧠 Join medical oncologists as they guide you through recognizing symptoms, diagnosis steps, and the significance of referrals to a #NET center of excellence for #pancreatic, #gastric, #rectal, and #appendiceal tumour types. 🎓 Access the video resources and earn your CME credits now! https://ow.ly/Cerm50Q76s3
Is there a criterion for choosing the secondary outcome or the second dependent variable? In an interventional study Is there a criterion for choosing the secondary outcome or the second dependent variable? Should these two variables in the study of medical sciences and especially nursing be conceptually related or not? For example: examining the effect of family-oriented empowerment on self-management and quality of life of cancer patients.
Just a few days to go until #ASCO24! Looking forward to meeting and discussing HCP medical education during the congress. If you're interested in arranging to meet and learn how we reach our global HCP audience, don't hesitate to get in touch (no pun intended). See you in Chicago! 😎 #cme #ime #medicaleducation #networking #oncology #medcomms #scicomms #medicalaffairs #scientificaffairs #meded #haematology
Missed Dr. Gustavo De Moraes, MD, PhD, MPH Xtalks webinar on Endpoints for Neuroprotection in Glaucoma Trials? Xtalks has your back with a recorded copy of the webinar! Dr. De Moraes, Chief Medical Officer at Ora and renowned glaucoma expert, shared groundbreaking program designs to better measure therapeutic impact of investigational products and IOP-independent neuroprotection. As companies delve into new glaucoma therapies for neuroprotection or enhancement, finding effective clinical approaches and endpoints is crucial. If you couldn't attend, register using the link below to receive the recording and stay up-to-date with the cutting-edge developments in glaucoma treatment! #ophthalmology #clinicalresearch #glaucoma